Cigna Group (NYSE:CI) Updates FY 2026 Earnings Guidance

Cigna Group (NYSE:CI) updated its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 30.450- for the period, compared to the consensus earnings per share estimate of 30.400. The company issued revenue guidance of -.

Cigna Group Trading Down 1.5%

Shares of NYSE:CI traded down $4.26 during trading hours on Friday, hitting $283.40. 746,943 shares of the company’s stock traded hands, compared to its average volume of 1,673,755. The business has a fifty day moving average price of $286.75 and a 200-day moving average price of $281.12. The firm has a market capitalization of $74.97 billion, a P/E ratio of 12.00, a price-to-earnings-growth ratio of 1.14 and a beta of 0.29. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the prior year, the firm earned $7.20 EPS. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities analysts expect that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. Cantor Fitzgerald lifted their price target on Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a research report on Friday, May 1st. The Goldman Sachs Group raised their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Piper Sandler reduced their target price on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Finally, Wells Fargo & Company increased their target price on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, Cigna Group has an average rating of “Moderate Buy” and an average price target of $341.60.

Insider Activity

In related news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported second-quarter adjusted earnings of $7.78 per share, exceeding analyst expectations, while total revenue increased 7% year over year to $71.7 billion. Growth in Cigna Healthcare and Evernorth’s pharmacy and specialty-drug businesses supported the results. Cigna second-quarter results
• Positive Sentiment: The company raised its 2026 adjusted earnings outlook to at least $30.45 per share, slightly above consensus, and is targeting approximately 10% earnings growth and mid-single-digit revenue growth through 2027. Reuters Cigna outlook
• Positive Sentiment: Analyst sentiment remains supportive: Barclays raised its price target from $304 to $310 while maintaining an Equal Weight rating. Cigna also has substantial financial flexibility, including $6.3 billion in cash, ongoing share repurchases and a $1.56-per-share dividend. Cigna valuation analysis
• Neutral Sentiment: At roughly 12 times earnings, Cigna remains viewed as deeply discounted relative to its earnings growth prospects. However, Barclays’ Equal Weight stance suggests the improved outlook may already be partly reflected in the valuation.
• Negative Sentiment: Management continues to face higher medical costs across the health-insurance industry. Cigna also expects slower growth in prescriptions for popular GLP-1 drugs, creating concern about the pace of future pharmacy-benefit growth. Cigna GLP-1 prescription outlook
• Negative Sentiment: Recent insider activity has been exclusively selling, including substantial sales by Chairman and CEO David Cordani. While such transactions may be routine, they can add to investor caution.

Institutional Investors Weigh In On Cigna Group

Hedge funds and other institutional investors have recently modified their holdings of the company. Sivia Capital Partners LLC raised its position in shares of Cigna Group by 10.4% in the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after buying an additional 109 shares in the last quarter. Brighton Jones LLC lifted its position in shares of Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after acquiring an additional 318 shares during the period. CreativeOne Wealth LLC grew its holdings in shares of Cigna Group by 6.5% during the 4th quarter. CreativeOne Wealth LLC now owns 1,648 shares of the health services provider’s stock worth $454,000 after purchasing an additional 100 shares in the last quarter. South Dakota Investment Council increased its position in shares of Cigna Group by 208.0% in the fourth quarter. South Dakota Investment Council now owns 1,540 shares of the health services provider’s stock worth $424,000 after purchasing an additional 1,040 shares during the period. Finally, Townsquare Capital LLC lifted its position in Cigna Group by 6.5% during the fourth quarter. Townsquare Capital LLC now owns 1,507 shares of the health services provider’s stock worth $415,000 after purchasing an additional 92 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.